Oral aqueous suspension comprising riluzole, a Surfactant selected from Anionic Surfactants, non-ionic Surfactants, or a mix of them, and a suspending Agent selected from smectite Clays, microcrystalline Cellulose, natural Gums or their mixtures, and their use for treating Amyotrophic Lateral Sclerosis (ALS).
Aqueous suspension comprising riluzole, at least one Surfactant and at least one suspension Agent, useful in the treatment of Amyotrophic lateral sclerosis.<；p>；Suspensió；n acuosa que comprende riluzol, al menos un tensoactivo y al menos un agente de suspensió；n, ú；til en el tratamiento de la esclerosis amiotró；fica lateral.<；/p>；
